Clinical Trial Update: Renal Denervation in Diabetic Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating renal denervation for diabetic nephropathy with persistent proteinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Persistent Proteinuria in Type 2 Diabetes Mellitus

Drugs mentioned

• Renal denervation device

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Diabetic Nephropathy, Persistent Proteinuria With Type II Diabetes | Phase 4 | Status: COMPLETED